Thyrocare Technologies IPO
Thyrocare Technologies IPO — date, price band, lot size & details 2016
Thyrocare Technologies listed on 9 May 2016 at ₹665, 49.1% above the ₹446 issue price.
Thyrocare Technologies is a pan India diagnostic chain that runs India's first fully automated diagnostic laboratory, serving over 2000 cities and towns. Its total income was Rs 187.05 crore in FY2015.
Stock price
Thyrocare Technologies is listed — here is the live share price.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
Timetable
Key dates from opening to listing. Today is 14 November.
- Open 27 Apr 2016
- Close 29 Apr 2016
- Allotment 05 May 2016
- Refund/credit TBA
- Listing 09 May 2016
Issue summary
The terms of the offer, as filed.
| IPO Dates | 27 to 29 Apr, 2016 |
|---|---|
| Price Band | ₹420 – ₹446 |
| Face Value | ₹10 |
| Lot Size | 33 Shares |
| Issue Size | ₹479.21 Cr |
| Sale Type | OFS only |
| Listing On | BSE, NSE |
| Registrar | MUFG Intime India Private Limited |
| Min Investment | ₹ 14,718 |
Share of the offer set aside for each investor category, as stated in the offer document.
What will it cost me?
Bidding is in multiples of 33 shares at the ₹446 cut-off. Drag to size your application.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 1 | 33 | ₹14,718 |
| Retail (max) | 13 | 429 | ₹1,91,334 |
| S-HNI (min) | 14 | 462 | ₹2,06,052 |
| S-HNI (max) | 67 | 2,211 | ₹9,86,106 |
| B-HNI (min) | 68 | 2,244 | ₹10,00,824 |
Strengths & risks
Drawn from the offer document — the case for and against, side by side.
Strengths · 4
- 01It had a presence in more than 2000 cities and towns and offered 192 tests.
- 02Total income rose from Rs 139.99 crore in FY2013 to Rs 187.05 crore in FY2015.
- 03Its profit margin is high, with Rs 48.45 crore of profit on Rs 187.05 crore of income in FY2015.
- 04Net worth rose from Rs 160.11 crore in FY2013 to Rs 375.70 crore on 31 December 2015, with no borrowing shown after FY2014.
Risks · 5
- 01Profit after tax fell from Rs 56.82 crore in FY2013 to Rs 46.16 crore in FY2014.
- 02Test quality is closely watched, and any lapse can hurt a diagnostics brand; total assets were Rs 399.66 crore.
- 03Diagnostics faces strong price competition; profit was Rs 43.59 crore in nine months to December 2015.
- 04The whole Rs 479.21 crore issue was an offer for sale, so none of it went to the company.
- 05Promoters held 64.96% before the issue and 63.96% after it.
Three years of numbers
All figures in ₹ crore, as reported in the Thyrocare Technologies offer document.
| Metric | 31 Dec 2015 | 31 Mar 2015 | 31 Mar 2014 | 31 Mar 2013 |
|---|---|---|---|---|
| Assets | 399.66 | 294.37 | 245.73 | 196.54 |
| Total Income | 174.55 | 187.05 | 156.56 | 139.99 |
| Profit After Tax | 43.59 | 48.45 | 46.16 | 56.82 |
| NET Worth | 375.70 | 278.92 | 206.26 | 160.11 |
| Reserves and Surplus | 321.97 | 228.38 | 195.35 | 149.19 |
| Total Borrowing | 25.00 | 25.00 |
See how this IPO compares — view listing performance of all mainboard IPOs.
Valuation & key ratios
Ratios are for the latest full financial year reported in the Thyrocare Technologies RHP.
Where the money goes
How the company intends to use the proceeds of the issue.
Information about the usage of proceeds from the Thyrocare Technologies IPO will be updated shortly.
Thyrocare Technologies IPO Anchor Investors
29 anchor investors across 11 fund houses committed ₹143.73 Cr a day before the issue opened.
Anchor investors bid a day before the issue opens and are locked in after allotment, so a book weighted towards domestic mutual funds is generally read as a stronger signal than one filled by short-horizon funds. Browse every anchor investor scheme or fund house we track.
About the company
It conducts medical diagnostic tests and test profiles that help with early detection and management of disorders and diseases.
It runs India's first fully automated diagnostic laboratory and has a presence in more than 2000 cities and towns in India and abroad. As of 30 November 2015 it offered 192 tests.
The IPO was Rs 479.21 crore and was entirely an offer for sale at Rs 446, the top of the Rs 420 to Rs 446 band, so the company received no money.
Interested in this IPO? Check the live subscription status or browse all upcoming mainboard IPOs.
The bankers & the filings
Who is running the book, and the documents this page is built from.
Thyrocare Technologies IPO Documents
Read the filings this page is built from.
Lead Manager Track Record
How the book-running lead managers on this issue have priced their past IPOs, measured on listing day.
JM Financial Ltd.
172 issues handledBest listing: Tata Technologies (+140.0%). Weakest: ACME Solar Holdings (-13.1%).
ICICI Securities
221 issues handledBest listing: Latent View Analytics (+160.0%). Weakest: Bannari Amman Spinning Mills (-25.2%).
Edelweiss Financial Services Ltd
73 issues handledBest listing: Route Mobile (+104.9%). Weakest: ICICI Securities (-16.3%).
Listing gain compares the listing-day opening price with the issue price, using the IPOs on IPO Guru that this lead manager has taken to market. A strong record reflects how the banker has priced past issues — it is not a forecast for this one. See every issue they have handled on the lead managers page.
Company contact
Frequently asked
What is the GMP of Thyrocare Technologies?
The current Grey Market Premium is ₹0.
What is the Thyrocare Technologies IPO price band?
₹420 to ₹446, on a face value of ₹10.
When is the allotment?
The basis of allotment is 5 May 2016, with listing on 9 May 2016.
How do I check allotment status?
On the IPO Guru allotment page or on the registrar's site — MUFG Intime India Private Limited.
Every number here traces back to a filing.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Every number on this page is sourced from the RHP, BSE & NSE.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
